EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas

Esmerina Tili, Teresa L Commisso, Veronica Balatti, Jean-Jacques Michaille, Gerard J Nuovo, Carlo M Croce iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2422615122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Esmerina Tili und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Wexner Medical Center, College of Medicine, The Ohio State University, Columbus, OH 43210. Hauptthemen laut MEDLINE: MicroRNAs, Lymphoma, Large B-Cell, Diffuse, Gene Expression Regulation, Neoplastic, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, R35, CLL Global Research Foundation (CLLGRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevated miR-155 levels in B cell malignancies, such as CLL and DLBCL, correlate with increased aggressiveness of the disease. We recently reported that, in two different mouse models of miR-155 -driven B cell malignancy, miR-155 targets and down-regulates transcripts encoding ICOSL, the ligand for the Inducible T cell costimulator (ICOS), thereby impairing the capacity of T lymphocytes to recognize and eliminate malignant cells. In this report, we extend our previous findings to Human by showing that miR-155 levels negatively correlate with those of both ICOSL and MHC-I in samples from DLBCL patients. We present evidence of miR-155 reducing the levels of ICOSL transcripts in ABC, but not in GCB primary tumors (PTs) and cell lines (CLs). In contrast, there was no evidence of miR-155 targeting MHC-I transcript levels in both types of DLBCLs. Nevertheless, miR-155 and MHC-I levels inversely correlated in DLBCLs samples, suggesting the existence of indirect regulatory effects of miR-155 . There was also evidence of dose-dependent effects at low miR-155 levels. Altogether, our findings indicate that the deficiency of both ICOSL and MHC-I activity, driven by high levels of miR-155 , may be causative in the failure of the host immune system to recognize and eliminate malignant B cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsLymphoma, Large B-Cell, DiffuseGene Expression Regulation, NeoplasticHistocompatibility Antigens Class IHumansInducible T-Cell Co-Stimulator LigandCell Line, TumorMiceAnimalsInducible T-Cell Co-Stimulator Protein

Stichwörter der Autor:innen

DLBCLICOSLMHC-IlymphomamicroRNA

Substanzen

MicroRNAsMIRN155 microRNA, humanInducible T-Cell Co-Stimulator LigandHistocompatibility Antigens Class IICOSLG protein, humanInducible T-Cell Co-Stimulator Protein

Autor:innen und Institutionen

  • Department of Anesthesiology, Wexner Medical Center, College of Medicine, The Ohio State University, Columbus, OH 43210.
  • Department of Cancer Biology and Genetics, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210.
  • Gnome, Powell, OH 43065.

ORCID-Profile: Carlo M Croce

Förderung

  • NCI NIH HHS
  • R35
  • CLL Global Research Foundation (CLLGRF)

Zitieren

APA

Tili, E., Commisso, T. L., Balatti, V., Michaille, J. J., Nuovo, G. J., & Croce, C. M. (2025). miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2422615122

Vancouver

Tili E, Commisso TL, Balatti V, Michaille JJ, Nuovo GJ, Croce CM. miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2422615122

BibTeX
@article{Tili2025,
  author = {Tili, Esmerina and Commisso, Teresa L and Balatti, Veronica and Michaille, Jean-Jacques and Nuovo, Gerard J and Croce, Carlo M},
  title = {miR-155 impairs ICOSL and MHC-I expression in DLBCL lymphomas},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2422615122}
}
Kostenlos starten →